Litcius/Paper detail

Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life

Hima Bindu Musunuru, Patrick Cheung, Danny Vesprini, Stanley K. Liu, William Chu, Hans T. Chung, Gerard Morton, Andrea Deabreu, Melanie Davidson, Ananth Ravi, Joelle Helou, Ling Ho, Liying Zhang, Andrew Loblaw

2021Radiotherapy and Oncology18 citationsDOI

Topics & Concepts

MedicineProstate cancerAndrogen deprivation therapyBrachytherapyUrologyQuality of life (healthcare)ProstateToxicityRadiation therapyInternal medicineCancerNursingProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchAdvanced Radiotherapy Techniques
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life | Litcius